Encompass Health Co. (NYSE:EHC) Receives Consensus Rating of "Buy" from Analysts

Encompass Health Co. (NYSE:EHC - Get Free Report) has been assigned an average recommendation of "Buy" from the eleven ratings firms that are presently covering the stock, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $107.11.

EHC has been the topic of several research reports. Truist Financial reissued a "buy" rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp boosted their price target on Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Royal Bank of Canada lifted their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, October 30th. Barclays lifted their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 29th. Finally, UBS Group raised their target price on Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a research note on Wednesday, September 25th.

Encompass Health Trading Down 0.1 %

Shares of Encompass Health stock traded down $0.07 during trading hours on Tuesday, reaching $92.35. The stock had a trading volume of 518,352 shares, compared to its average volume of 638,437. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health has a 1 year low of $65.99 and a 1 year high of $104.55. The firm has a market capitalization of $9.30 billion, a price-to-earnings ratio of 22.31, a P/E/G ratio of 1.30 and a beta of 0.86. The firm has a 50 day simple moving average of $99.07 and a two-hundred day simple moving average of $93.39.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating analysts' consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm had revenue of $1.35 billion for the quarter, compared to analysts' expectations of $1.33 billion. During the same period in the previous year, the company posted $0.86 earnings per share. Encompass Health's revenue was up 11.9% compared to the same quarter last year. As a group, equities research analysts anticipate that Encompass Health will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's payout ratio is 16.43%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Point72 Asset Management L.P. grew its stake in shares of Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock worth $83,990,000 after purchasing an additional 835,135 shares during the last quarter. Magnetar Financial LLC grew its stake in Encompass Health by 1,176.6% in the second quarter. Magnetar Financial LLC now owns 744,836 shares of the company's stock valued at $63,899,000 after purchasing an additional 814,018 shares in the last quarter. Thrivent Financial for Lutherans raised its position in Encompass Health by 2,302.7% during the second quarter. Thrivent Financial for Lutherans now owns 603,558 shares of the company's stock valued at $51,780,000 after acquiring an additional 578,438 shares in the last quarter. AQR Capital Management LLC boosted its holdings in Encompass Health by 213.3% in the second quarter. AQR Capital Management LLC now owns 207,202 shares of the company's stock worth $17,776,000 after purchasing an additional 141,075 shares in the last quarter. Finally, Franklin Resources Inc. grew its holdings in Encompass Health by 22.0% during the third quarter. Franklin Resources Inc. now owns 700,021 shares of the company's stock valued at $67,412,000 after purchasing an additional 126,000 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.